Apeiron Investment Group Ltd., 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 223,230 shares at $4.83 ($1.1M) on 2022-04-11, disclosed to the SEC on 2022-04-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.81 | 57,689 | $277K | 25.8% |
| 2 | $4.81 | 57,689 | $277K | 25.8% |
| 3 | $4.83 | 53,926 | $260K | 24.2% |
| 4 | $4.83 | 53,926 | $260K | 24.2% |
| Total | $4.82 avg | 223,230 | $1.1M | 100% |
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |